SCHEMBL19804585

SCHEMBL19804585

C=CC(=O)OCc1cc(C2CCCCC2)ccc1-c1ccc(OCC(CO)CO)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR4 Q5NUL3 7/20 0.45
APP P05067 1/20 0.34
HRH3 Q9Y5N1 1/20 0.34
MEN1 O00255 1/20 0.33
NPC1 O15118 1/20 0.33
POLB P06746 1/20 0.33
RAB9A P51151 1/20 0.33
BLM P54132 1/20 0.33
KMT2A Q03164 1/20 0.33
GPR35 Q9HC97 1/20 0.33
THRB P10828 1/20 0.33
CYP3A4 P08684 2/20 0.32
CYP2C9 P11712 1/20 0.32
PPARG P37231 2/20 0.32
PPARA Q07869 1/20 0.32
FFAR1 O14842 2/20 0.32
HIF1A Q16665 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
ALDH1A1 P00352 1/20 0.31
MAPT P10636 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19624624 0.91 FFAR4 (0.40) FFAR4APPTHRBFFAR1
SCHEMBL19796905 0.85 FFAR4 (0.38) FFAR4RAB9ATHRBCYP2C9PPARG
SCHEMBL19804771 0.83 FFAR4 (0.48) FFAR4APPHRH3MEN1NPC1
SCHEMBL19804302 0.81 FFAR1 (0.41) FFAR4APPMEN1KMT2ATHRB
SCHEMBL19796450 0.78 THRB (0.44) FFAR4APPTHRBPPARAFFAR1
SCHEMBL19804599 0.77 FFAR4 (0.46) FFAR4APPHRH3MEN1NPC1
SCHEMBL19804804 0.76 FFAR4 (0.42) FFAR4APPHRH3MEN1NPC1
SCHEMBL19804552 0.76 PTGDR (0.35) FFAR4APPTHRBCYP3A4CYP2C9
SCHEMBL19804568 0.75 THRB (0.46) FFAR4APPHRH3MEN1NPC1
SCHEMBL19804667 0.75 FFAR4 (0.43) FFAR4APPMEN1KMT2ATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-01-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180023001-A1 COMPOUND HAVING POLYMERIZABLE GROUP, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, C1S, AP3D1 FFAR4 1715/4885APP 325/4885HRH3 661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.